In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...
Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...
In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...
Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...
India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...
Among these sensors, we further focused on the spatiotemporal dynamics of Rab10 and Rab4 activity during sLTP. We found that postsynaptic stimulation leads to the persistent inactivation of Rab10 and ...
The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...
Scientists from NPL, working in collaboration with AI experts from IBM and the Science and Technology facilities Council ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...
BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback